138 related articles for article (PubMed ID: 15635072)
1. A PDGFRA promoter polymorphism, which disrupts the binding of ZNF148, is associated with primitive neuroectodermal tumours and ependymomas.
De Bustos C; Smits A; Strömberg B; Collins VP; Nistér M; Afink G
J Med Genet; 2005 Jan; 42(1):31-7. PubMed ID: 15635072
[TBL] [Abstract][Full Text] [Related]
2. Promoter haplotype combinations of the platelet-derived growth factor alpha-receptor gene predispose to human neural tube defects.
Joosten PH; Toepoel M; Mariman EC; Van Zoelen EJ
Nat Genet; 2001 Feb; 27(2):215-7. PubMed ID: 11175793
[TBL] [Abstract][Full Text] [Related]
3. Somatic mutations in the neurofibromatosis 1 gene in gliomas and primitive neuroectodermal tumours.
Thiel G; Marczinek K; Neumann R; Witkowski R; Marchuk DA; Nurnberg P
Anticancer Res; 1995; 15(6B):2495-9. PubMed ID: 8669813
[TBL] [Abstract][Full Text] [Related]
4. Variant in promoter region of platelet-derived growth factor receptor-alpha (PDGFRalpha) gene is associated with the severity and allergic status of childhood asthma.
Wu LS; Tan CY; Wang LM; Lin CG; Wang JY
Int Arch Allergy Immunol; 2006; 141(1):37-46. PubMed ID: 16804324
[TBL] [Abstract][Full Text] [Related]
5. Haplotype-dependent binding of nuclear proteins to the promoter of the neural tube defects-associated platelet-derived growth factor alpha-receptor gene.
Toepoel M; Ackerschott B; van Zoelen EJ
Biochim Biophys Acta; 2005 Sep; 1741(3):350-7. PubMed ID: 16126374
[TBL] [Abstract][Full Text] [Related]
6. Shared molecular targets in pediatric gliomas and ependymomas.
Tsuruta T; Aihara Y; Kanno H; Funase M; Murayama T; Osawa M; Fujii H; Kubo O; Okada Y
Pediatr Blood Cancer; 2011 Dec; 57(7):1117-23. PubMed ID: 21298772
[TBL] [Abstract][Full Text] [Related]
7. No evidence for mutations or altered expression of the Suppressor of Fused gene (SUFU) in primitive neuroectodermal tumours.
Koch A; Waha A; Hartmann W; Milde U; Goodyer CG; Sörensen N; Berthold F; Digon-Söntgerath B; Krätzschmar J; Wiestler OD; Pietsch T
Neuropathol Appl Neurobiol; 2004 Oct; 30(5):532-9. PubMed ID: 15488029
[TBL] [Abstract][Full Text] [Related]
8. Mutation and expression of PDGFRA and KIT in malignant peripheral nerve sheath tumors, and its implications for imatinib sensitivity.
Holtkamp N; Okuducu AF; Mucha J; Afanasieva A; Hartmann C; Atallah I; Estevez-Schwarz L; Mawrin C; Friedrich RE; Mautner VF; von Deimling A
Carcinogenesis; 2006 Mar; 27(3):664-71. PubMed ID: 16357008
[TBL] [Abstract][Full Text] [Related]
9. Autocrine platelet-derived growth factor-dependent gene expression in glioblastoma cells is mediated largely by activation of the transcription factor sterol regulatory element binding protein and is associated with altered genotype and patient survival in human brain tumors.
Ma D; Nutt CL; Shanehsaz P; Peng X; Louis DN; Kaetzel DM
Cancer Res; 2005 Jul; 65(13):5523-34. PubMed ID: 15994924
[TBL] [Abstract][Full Text] [Related]
10. A functional common polymorphism in a Sp1 recognition site of the epidermal growth factor receptor gene promoter.
Liu W; Innocenti F; Wu MH; Desai AA; Dolan ME; Cook EH; Ratain MJ
Cancer Res; 2005 Jan; 65(1):46-53. PubMed ID: 15665278
[TBL] [Abstract][Full Text] [Related]
11. Haplotype-specific expression of the human PDGFRA gene correlates with the risk of glioblastomas.
Toepoel M; Joosten PHLJ; Knobbe CB; Afink GB; Zotz RB; Steegers-Theunissen RPM; Reifenberger G; van Zoelen EJJ
Int J Cancer; 2008 Jul; 123(2):322-329. PubMed ID: 18464291
[TBL] [Abstract][Full Text] [Related]
12. Amplification of KIT, PDGFRA, VEGFR2, and EGFR in gliomas.
Puputti M; Tynninen O; Sihto H; Blom T; Mäenpää H; Isola J; Paetau A; Joensuu H; Nupponen NN
Mol Cancer Res; 2006 Dec; 4(12):927-34. PubMed ID: 17189383
[TBL] [Abstract][Full Text] [Related]
13. PDGFRalpha- and c-kit-mutated gastrointestinal stromal tumours (GISTs) are characterized by distinctive histological and immunohistochemical features.
Pauls K; Merkelbach-Bruse S; Thal D; Büttner R; Wardelmann E
Histopathology; 2005 Feb; 46(2):166-75. PubMed ID: 15693889
[TBL] [Abstract][Full Text] [Related]
14. Promoter hypermethylation profile of RASSF1A, FHIT, and sFRP1 in intracranial primitive neuroectodermal tumors.
Chang Q; Pang JC; Li KK; Poon WS; Zhou L; Ng HK
Hum Pathol; 2005 Dec; 36(12):1265-72. PubMed ID: 16311119
[TBL] [Abstract][Full Text] [Related]
15. Amplification of genes encoding KIT, PDGFRalpha and VEGFR2 receptor tyrosine kinases is frequent in glioblastoma multiforme.
Joensuu H; Puputti M; Sihto H; Tynninen O; Nupponen NN
J Pathol; 2005 Oct; 207(2):224-31. PubMed ID: 16021678
[TBL] [Abstract][Full Text] [Related]
16. Significant associations of the mitochondrial transcription factor A promoter polymorphisms with marbling and subcutaneous fat depth in Wagyu x Limousin F2 crosses.
Jiang Z; Kunej T; Michal JJ; Gaskins CT; Reeves JJ; Busboom JR; Dovc P; Wright RW
Biochem Biophys Res Commun; 2005 Aug; 334(2):516-23. PubMed ID: 16005429
[TBL] [Abstract][Full Text] [Related]
17. Interaction of PDGFRA promoter haplotypes and maternal environmental exposures in the risk of spina bifida.
Toepoel M; Steegers-Theunissen RP; Ouborg NJ; Franke B; González-Zuloeta Ladd AM; Joosten PH; van Zoelen EJ
Birth Defects Res A Clin Mol Teratol; 2009 Jul; 85(7):629-36. PubMed ID: 19215021
[TBL] [Abstract][Full Text] [Related]
18. The distribution of SNPs in human gene regulatory regions.
Guo Y; Jamison DC
BMC Genomics; 2005 Oct; 6():140. PubMed ID: 16209714
[TBL] [Abstract][Full Text] [Related]
19. Sox10 has a broad expression pattern in gliomas and enhances platelet-derived growth factor-B--induced gliomagenesis.
Ferletta M; Uhrbom L; Olofsson T; Pontén F; Westermark B
Mol Cancer Res; 2007 Sep; 5(9):891-7. PubMed ID: 17855658
[TBL] [Abstract][Full Text] [Related]
20. Polymorphisms in GLTSCR1 and ERCC2 are associated with the development of oligodendrogliomas.
Yang P; Kollmeyer TM; Buckner K; Bamlet W; Ballman KV; Jenkins RB
Cancer; 2005 Jun; 103(11):2363-72. PubMed ID: 15834925
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
